• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Stem cells and the heart-the road ahead.

作者信息

Murry Charles E, MacLellan W Robb

机构信息

Center for Cardiovascular Biology and Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.

Sana Biotechnology, Seattle, WA 98102, USA.

出版信息

Science. 2020 Feb 21;367(6480):854-855. doi: 10.1126/science.aaz3650.

DOI:10.1126/science.aaz3650
PMID:32079761
Abstract
摘要

相似文献

1
Stem cells and the heart-the road ahead.干细胞与心脏——未来之路
Science. 2020 Feb 21;367(6480):854-855. doi: 10.1126/science.aaz3650.
2
Cell-based cardiac regeneration.基于细胞的心脏再生
Eur Heart J. 2017 Apr 14;38(15):1095-1098. doi: 10.1093/eurheartj/ehx152.
3
Power Is Nothing Without Control: The Enduring Search for the Best Cell in Cardiac Cell Therapy at a Crossroads.没有控制，力量便毫无意义：心脏细胞治疗处于十字路口，对最佳细胞的不懈探索仍在继续。
Circ Res. 2016 Oct 14;119(9):988-991. doi: 10.1161/CIRCRESAHA.116.309619.
4
Making Cardiomyocytes from Pluripotent Stem Cells.诱导多能干细胞分化为心肌细胞。
Methods Mol Biol. 2021;2320:3-7. doi: 10.1007/978-1-0716-1484-6_1.
5
Vasculogenically conditioned peripheral blood mononuclear cells inhibit mouse immune response to induced pluripotent stem cell-derived allogeneic cardiac grafts.条件外周血单核细胞抑制小鼠对诱导多能干细胞源性同种异体心脏移植物的免疫反应。
PLoS One. 2019 May 28;14(5):e0217076. doi: 10.1371/journal.pone.0217076. eCollection 2019.
6
Advanced cell and gene therapies in cardiology.心脏病学中的先进细胞和基因疗法。
EBioMedicine. 2024 May;103:105125. doi: 10.1016/j.ebiom.2024.105125. Epub 2024 Apr 18.
7
Stem cells: A step closer to cardiac repair therapies.干细胞：离心脏修复疗法又近一步。
Nat Rev Cardiol. 2016 Dec;13(12):695. doi: 10.1038/nrcardio.2016.178. Epub 2016 Oct 27.
8
Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.多能干细胞衍生心肌细胞在心脏细胞治疗及作为疾病模型方面的前景。
J Cell Biochem. 2009 Jul 1;107(4):592-9. doi: 10.1002/jcb.22164.
9
[Review of basic studies about the cardiac stem cell and regenerative medicine].[关于心脏干细胞与再生医学的基础研究综述]
Nihon Rinsho. 2008 May;66(5):908-14.
10
Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?用人诱导多能干细胞进行安全有效的心脏再生治疗：我们应如何制备纯心肌细胞？
Circ Res. 2017 May 12;120(10):1558-1560. doi: 10.1161/CIRCRESAHA.116.310328.

引用本文的文献

1
Advancing ex vivo functional whole-organ prostate gland model for regeneration and drug screening.用于再生和药物筛选的先进离体功能性全器官前列腺模型。
Sci Rep. 2025 Jan 30;15(1):3758. doi: 10.1038/s41598-025-87039-y.
2
Matrix Architecture and Mechanics Regulate Myofibril Organization, Costamere Assembly, and Contractility in Engineered Myocardial Microtissues.基质结构与力学调控工程化心肌微组织中的肌原纤维组织、肋状肌附着点组装及收缩性。
Adv Sci (Weinh). 2024 Dec;11(47):e2309740. doi: 10.1002/advs.202309740. Epub 2024 Nov 18.
3
Insights into the prospects of nanobiomaterials in the treatment of cardiac arrhythmia.纳米生物材料在治疗心律失常方面的前景展望。
J Nanobiotechnology. 2024 Aug 30;22(1):523. doi: 10.1186/s12951-024-02805-w.
4
Inhalable Stem Cell Exosomes Promote Heart Repair After Myocardial Infarction.可吸入干细胞外泌体促进心肌梗死后的心脏修复。
Circulation. 2024 Aug 27;150(9):710-723. doi: 10.1161/CIRCULATIONAHA.123.065005. Epub 2024 Aug 26.
5
Editorial: Constructing the vascular or cardiac tissue and organoids: the combination of biomedicine and engineering.社论：构建血管或心脏组织及类器官：生物医学与工程学的结合
Front Cardiovasc Med. 2024 Feb 16;11:1371074. doi: 10.3389/fcvm.2024.1371074. eCollection 2024.
6
Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts.纳米线引导的人心肌类器官移植可实现对梗死心脏的高效且有效的恢复。
Sci Adv. 2023 Aug 4;9(31):eadf2898. doi: 10.1126/sciadv.adf2898.
7
Contemporary Challenges of Regenerative Therapy in Patients with Ischemic and Non-Ischemic Heart Failure.缺血性和非缺血性心力衰竭患者再生治疗的当代挑战
J Cardiovasc Dev Dis. 2022 Dec 1;9(12):429. doi: 10.3390/jcdd9120429.
8
Challenges and opportunities for the next generation of cardiovascular tissue engineering.下一代心血管组织工程面临的挑战与机遇。
Nat Methods. 2022 Sep;19(9):1064-1071. doi: 10.1038/s41592-022-01591-3. Epub 2022 Sep 5.
9
Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review.间充质干细胞在再生医学中的临床应用：叙述性综述。
Stem Cell Res Ther. 2022 Jul 28;13(1):366. doi: 10.1186/s13287-022-03054-0.
10
The road to physiological maturation of stem cell-derived cardiac muscle runs through the sarcomere.干细胞衍生心肌的生理成熟之路要经过肌节。
J Mol Cell Cardiol. 2022 Sep;170:117-120. doi: 10.1016/j.yjmcc.2022.06.005. Epub 2022 Jun 23.